Cargando…

COVID-19 vaccination recruits and matures cross-reactive antibodies to conserved epitopes in endemic coronavirus Spike proteins

The COVID-19 pandemic has triggered the first widespread vaccination campaign against a coronavirus. Most vaccinated subjects are naïve to SARS-CoV-2, however almost all have previously encountered other coronaviruses (CoVs) and the role of this immunity in shaping the vaccine response remains uncha...

Descripción completa

Detalles Bibliográficos
Autores principales: Elko, Evan A, Nelson, Georgia A, Mead, Heather L, Kelley, Erin J, Le Verche, Virginia, Cardoso, Angelo A, Ely, Jennifer L, Boyle, Annalee S, Piña, Alejandra, Henson, Sierra N, Rahee, Fatima, Keim, Paul S, Celona, Kimberly R, Yi, Jinhee, Settles, Erik W, Yu, George C, Morris, Sheldon R, Zaia, John A, Ladner, Jason T, Altin, John A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811912/
https://www.ncbi.nlm.nih.gov/pubmed/35118479
http://dx.doi.org/10.1101/2022.01.24.22269542
Descripción
Sumario:The COVID-19 pandemic has triggered the first widespread vaccination campaign against a coronavirus. Most vaccinated subjects are naïve to SARS-CoV-2, however almost all have previously encountered other coronaviruses (CoVs) and the role of this immunity in shaping the vaccine response remains uncharacterized. Here we use longitudinal samples and highly-multiplexed serology to identify mRNA-1273 vaccine-induced antibody responses against a range of CoV Spike epitopes and in both phylogenetically conserved and non-conserved regions. Whereas reactivity to SARS-CoV-2 epitopes showed a delayed but progressive increase following vaccination, we observed distinct kinetics for the endemic CoV homologs at two conserved sites in Spike S2: these became detectable sooner, and decayed at later timepoints. Using homolog-specific depletion and alanine-substitution experiments, we show that these distinctly-evolving specificities result from cross-reactive antibodies as they mature against rare, polymorphic residues within these epitopes. Our results reveal mechanisms for the formation of antibodies with broad reactivity against CoVs.